Teva Pharmaceutical Industries Insider Sold Shares Worth $6,294,031, According to a Recent SEC Filing-February 2024-www.financetom.com

Teva Pharmaceutical Industries Insider Sold Shares Worth $6,294,031, According to a Recent SEC Filing

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Teva Pharmaceutical Industries Insider Sold Shares Worth $6,294,031, According to a Recent SEC Filing

Dec 26, 2024 1:32 PM

04:08 PM EST, 12/26/2024 (MT Newswires) -- Roberto Mignone, Director, on December 20, 2024, sold 286,000 shares in Teva Pharmaceutical Industries ( TEVA ) for $6,294,031. Following the Form 4 filing with the SEC, Mignone has control over a total of 790,683 shares of the company, with 95,683 shares held directly and 695,000 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/818686/000095017024140391/xslF345X05/ownership.xml

Previous page： Corcept Therapeutics Insider Sold Shares Worth $430,475, According to a Recent SEC Filing Next page： Cencora Insider Sold Shares Worth $1,661,363, According to a Recent SEC Filing

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Corcept Therapeutics Insider Sold Shares Worth $430,475, According to a Recent SEC Filing

Mar 21, 2024

10:42 AM EDT, 03/21/2024 (MT Newswires) -- Sean Maduck, President, Corcept Endocrinology, on March 18, 2024, sold 17,219 shares in Corcept Therapeutics ( CORT ) for $430,475. Following the Form 4 filing with the SEC, Maduck has control over a total of 95,222 shares of the company, with 75,222 shares held directly and 20,000 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1088856/000095017024034264/xslF345X03/ownership.xml Price:...

Cencora Insider Sold Shares Worth $1,661,363, According to a Recent SEC Filing

Mar 21, 2024

10:43 AM EDT, 03/21/2024 (MT Newswires) -- Elizabeth S Campbell, Executive Vice President, on March 18, 2024, sold 6,977 shares in Cencora ( COR ) for $1,661,363. Following the Form 4 filing with the SEC, Campbell has control over a total of 8,246 shares of the company, with 8,246 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1140859/000114085924000056/xslF345X03/wk-form4_1710966227.xml Price: 242.08, Change: +0.21, Percent...

Abbvie Insider Sold Shares Worth $10,539,508, According to a Recent SEC Filing

Mar 21, 2024

10:43 AM EDT, 03/21/2024 (MT Newswires) -- Jeffrey Ryan Stewart, Executive Vice President, Chief Commercial Officer, on March 18, 2024, sold 58,949 shares in Abbvie ( ABBV ) for $10,539,508. Following the Form 4 filing with the SEC, Stewart has control over a total of 62,279 shares of the company, with 60,941 shares held directly and 1,338 controlled indirectly. SEC...

US FDIC draft proposal: bank mergers above $100 billion get extra scrutiny

Mar 21, 2024

(Reuters) - Mergers that could result in banks with more than $100 billion in assets should expect heightened scrutiny from the U.S. Federal Deposit Insurance Corporation, according to draft guidance the agency released Thursday. The FDIC's board of directors is poised to vote on the proposal on Thursday. If adopted, the proposal would update the agency's merger guidance for the...